Asset Portfolio
Asset Portfolio
Asset Portfolio
Small Molecule
Small Molecule
Asset #
Asset #
Therapeutic Area
Therapeutic Area
Target
Target
Stage of Developement
Stage of Developement
SG1072
SG1072
Oncology
Oncology
Microtubule Stabilizing Agent (iv)
Microtubule Stabilizing Agent (iv)
Launched in China
Launched in China
SG1073
SG1073
Oncology
Oncology
Microtubule Stabilizing Agent (oral)
Microtubule Stabilizing Agent (oral)
Microtubule Stabilizing Agent (oral)
Phase 3 in China
Phase 3 in China
SG1074
SG1074
Oncology
Oncology
CDK 4/6 (brain penetrant)
CDK 4/6 (brain penetrant)
CDK 4/6 (brain penetrant)
Phase 1 in China
Phase 1 in China
SG1075
SG1075
Oncology
Oncology
CDK 9 (brain penetrant)
CDK 9 (brain penetrant)
CDK 9 (brain penetrant)
IND Ready
IND Ready
Large Molecule
Large Molecule
Asset #
Asset #
Therapeutic Area
Therapeutic Area
Target
Target
Stage of Developement
Stage of Developement
SG2037
SG2037
Oncology/Immunology
Oncology/Immunology
CD20/CD3
CD20/CD3
Phase 1 in China
Phase 1 in China
SG2043
SG2043
Oncology/Immunology
Oncology/Immunology
BCMA/CD3
BCMA/CD3
Phase 1 in China
Phase 1 in China
SG2044
SG2044
Oncology/Immunology
Oncology/Immunology
CD19/CD3
CD19/CD3
Phase 1 in China
Phase 1 in China
Phase 1 in China
SG2045
SG2045
Immunology
Immunology
BCMA/CD19/CD3
BCMA/CD19/CD3
Preclinical
Preclinical
Preclinical
SG2046
SG2046
RA, Osteoporosis
RA, Osteoporosis
TNFa/RANKL
TNFa/RANKL
IND Ready
IND Ready
IND Ready
SG2047
SG2047
RA, SLE, IaA Neophropathy
RA, SLE, IaA Neophropathy
RA, SLE, IgA Neophropathy
TNFa/BAFF/APRIL
TNFa/BAFF/APRIL
Phase 2 in China
Phase 2 in China
Phase 2 in China
SG2048
SG2048
Hypertriglyceridemia
Hypertriglyceridemia
APOC3 (SiRNA)
APOC3 (SiRNA)
IND Ready
IND Ready
IND Ready
SG2049
SG2049
Coagulation
Coagulation
Factor XI (SiRNA)
Factor XI (SiRNA)
Phase 1 in China
Phase 1 in China
SG2050
SG2050
Oncology
Oncology
B7H3/CD3
B7H3/CD3
IND Ready
IND Ready
IND Ready
SG2051
SG2051
Cosmetics
Cosmetics
TGF-b1/COX-2
TGF-b1/COX-2
Phase 1 in US completed
Phase 1 in US completed
ADC
ADC
Asset #
Asset #
Therapeutic Area
Therapeutic Area
Target
Target
Stage of Developement
Stage of Developement
Cell Therapy
Cell Therapy
Asset #
Asset #
Therapeutic Area
Therapeutic Area
Target
Target
Stage of Developement
Stage of Developement
SG6001
SG6001
Oncology
Oncology
GBM
GBM
IIT
IIT
SG6002
SG6002
Neuro
Neuro
Parkinson's
Parkinson's
Phase 1 in USA/China
Phase 1 in USA/China
Legal
© 2025 by Conexus Bio.
Legal
© 2025 by Conexus Bio.
Legal
© 2025 by Conexus Bio.